Incyte Corp. (INCY)
106.21
+0.97
(+0.92%)
USD |
NASDAQ |
Jan 16, 16:00
106.50
+0.29
(+0.27%)
After-Hours: 20:00
Incyte EPS Diluted (Quarterly): 2.106 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Pfizer Inc. | 0.6197 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Bio-Techne Corp. | 0.2442 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 424.17M |
| Revenue (Quarterly) | 1.366B |
| Total Expenses (Quarterly) | 941.81M |
| Enterprise Value | 17.96B |
| Gross Profit Margin (Quarterly) | 91.50% |
| Profit Margin (Quarterly) | 31.05% |
| Earnings Yield | 5.61% |
| Operating Earnings Yield | 5.95% |
| Normalized Earnings Yield | 4.860 |